Volume 11, Number 1—January 2005
Research
Border Screening for SARS
Table 3
Travel histories of persons departing from Canada in whom a SARS-like illness was subsequently diagnosed*
| Case no. | Age | Sex | Depart date, Toronto | Onset of illness | Probable SARS† | Link‡ | Remarks |
|---|---|---|---|---|---|---|---|
| 1 | 3 | F | March 28 | March 31 | Yes | No | PCR negative for SARS-CoV |
| 2 | 5 | M | March 28 | March 25 | Yes | No | No evidence of pneumonia, PCR negative for SARS-CoV |
| 3 | 1 | M | March 28 | April 1 | Yes | No | No evidence of pneumonia, PCR negative for SARS-CoV |
| 4 | 26 | F | March 31 | April 3 | Yes | No | PCR and serologic test results negative for SAR-CoV |
| 5 | 52 | M | April 1 | April 3 | Yes | Yes | Traveled by car, PCR and serologic test results positive for SARS-CoV |
| 6 | 46 | F | April 3 | April 6 | Yes | Yes | Fatal SARS case |
| 7 | 24 | M | April 28 | April 30 | Yes | No | Serologic and PCR test results negative for SARS-CoV |
| 8 | 28 | F | April 24 | May 3 | Yes | No | No laboratory results available |
| 9 | 29 | M | May 10 | May 13 | Yes | No | Traveled by car, PCR negative and acute serologic test results negative for SARS-CoV (convalescent-phase serologic test results not available) |
| 10 | 47 | M | May 17 | May 24 | Yes | Yes | Acute–phase serologic test results positive for SARS-CoV |
| 11 | 25 | M | July 14 | July 7 | Yes | No | Laboratory results unavailable |
*SARS, severe acute respiratory syndrome; F, female; M. male; SARS-CoV, SARS-associated coronavirus; PCR, polymerase chain reaction.
†Met the World Health Organization probable SARS case definition at time of illness.
‡Is an epidemiologic link to another SARS case established?
Page created: April 15, 2011
Page updated: April 15, 2011
Page reviewed: April 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.